Principal Investigator
Ana Abrantes
Status
Ongoing
The completed, pilot phase of this study produced a 12-week Wisepill device+SMS (text) intervention for individuals in intensive outpatient alcohol treatment who are prescribed disulfiram. The Wisepill device is a medication monitoring system equipped with technology that allows text messages to be delivered to the user. The current RCT is enrolling 75 participants with alcohol use disorder who recently initiated disulfiram. Participants are randomized into one of the following conditions: (1.) Wisepill+SMS intervention, (2.) Wisepill only (i.e.no SMS messaging), or (3.) Disulfiram only (i.e. no Wisepill). Follow-up assessments will occur at the 1-, 2-, 3- (end of intervention), and 6-month time points. Researchers will assess alcohol use, medication adherence, coping, self-efficacy, and perceived social support.